vs
自然阳光（NATR）与PDF SOLUTIONS INC（PDFS）财务数据对比。点击上方公司名可切换其他公司
自然阳光的季度营收约是PDF SOLUTIONS INC的2.0倍（$123.8M vs $62.4M），自然阳光净利率更高（3.3% vs -0.1%，领先3.4%），PDF SOLUTIONS INC同比增速更快（24.6% vs 4.7%），自然阳光自由现金流更多（$7.6M vs $7.5M），过去两年PDF SOLUTIONS INC的营收复合增速更高（22.9% vs 5.6%）
自然阳光产品公司（简称NSP）主营膳食补充剂与个人护理产品的生产制造，产品涵盖草本补充剂、维生素、矿物质制剂等品类。公司总部设于犹他州利希，生产工厂位于犹他州西班牙福克，是该领域知名的健康产品生产商。
PDF Solutions Inc是一家总部位于美国加利福尼亚州圣克拉拉的跨国企业，主营软件业务与工程技术服务，目前在纳斯达克交易所挂牌上市，股票代码为PDFS。
NATR vs PDFS — 直观对比
营收规模更大
NATR
是对方的2.0倍
$62.4M
营收增速更快
PDFS
高出19.9%
4.7%
净利率更高
NATR
高出3.4%
-0.1%
自由现金流更多
NATR
多$11.0K
$7.5M
两年增速更快
PDFS
近两年复合增速
5.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $123.8M | $62.4M |
| 净利润 | $4.1M | $-48.0K |
| 毛利率 | 72.5% | 72.9% |
| 营业利润率 | 4.3% | 5.5% |
| 净利率 | 3.3% | -0.1% |
| 营收同比 | 4.7% | 24.6% |
| 净利润同比 | 1379.4% | -108.9% |
| 每股收益（稀释后） | $0.23 | $0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NATRPDFS
| Q4 25 | $123.8M | $62.4M | ||
| Q3 25 | $128.3M | $57.1M | ||
| Q2 25 | $114.8M | $51.7M | ||
| Q1 25 | $113.2M | $47.8M | ||
| Q4 24 | $118.2M | $50.1M | ||
| Q3 24 | $114.6M | $46.4M | ||
| Q2 24 | $110.6M | $41.7M | ||
| Q1 24 | $111.0M | $41.3M |
净利润NATRPDFS
| Q4 25 | $4.1M | $-48.0K | ||
| Q3 25 | $5.3M | $1.3M | ||
| Q2 25 | $5.3M | $1.1M | ||
| Q1 25 | $4.7M | $-3.0M | ||
| Q4 24 | $-321.0K | $539.0K | ||
| Q3 24 | $4.3M | $2.2M | ||
| Q2 24 | $1.3M | $1.7M | ||
| Q1 24 | $2.3M | $-393.0K |
毛利率NATRPDFS
| Q4 25 | 72.5% | 72.9% | ||
| Q3 25 | 73.3% | 72.3% | ||
| Q2 25 | 71.7% | 71.2% | ||
| Q1 25 | 72.1% | 72.9% | ||
| Q4 24 | 72.0% | 68.3% | ||
| Q3 24 | 71.3% | 73.1% | ||
| Q2 24 | 71.4% | 70.6% | ||
| Q1 24 | 71.2% | 67.3% |
营业利润率NATRPDFS
| Q4 25 | 4.3% | 5.5% | ||
| Q3 25 | 7.0% | 8.5% | ||
| Q2 25 | 3.7% | 2.2% | ||
| Q1 25 | 5.4% | -7.4% | ||
| Q4 24 | 3.8% | 1.0% | ||
| Q3 24 | 4.6% | 4.6% | ||
| Q2 24 | 5.1% | 0.6% | ||
| Q1 24 | 4.2% | -4.7% |
净利率NATRPDFS
| Q4 25 | 3.3% | -0.1% | ||
| Q3 25 | 4.2% | 2.3% | ||
| Q2 25 | 4.6% | 2.2% | ||
| Q1 25 | 4.2% | -6.3% | ||
| Q4 24 | -0.3% | 1.1% | ||
| Q3 24 | 3.8% | 4.8% | ||
| Q2 24 | 1.2% | 4.1% | ||
| Q1 24 | 2.1% | -1.0% |
每股收益（稀释后）NATRPDFS
| Q4 25 | $0.23 | $0.00 | ||
| Q3 25 | $0.30 | $0.03 | ||
| Q2 25 | $0.28 | $0.03 | ||
| Q1 25 | $0.25 | $-0.08 | ||
| Q4 24 | $-0.02 | $0.01 | ||
| Q3 24 | $0.23 | $0.06 | ||
| Q2 24 | $0.07 | $0.04 | ||
| Q1 24 | $0.12 | $-0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $93.9M | $42.2M |
| 总债务越低越好 | — | $67.0M |
| 股东权益账面价值 | $161.6M | $271.0M |
| 总资产 | $261.1M | $418.7M |
| 负债/权益比越低杠杆越低 | — | 0.25× |
8季度趋势，按日历期对齐
现金及短期投资NATRPDFS
| Q4 25 | $93.9M | $42.2M | ||
| Q3 25 | $95.6M | $35.9M | ||
| Q2 25 | $81.3M | $40.4M | ||
| Q1 25 | $86.5M | $54.1M | ||
| Q4 24 | $84.7M | $114.9M | ||
| Q3 24 | $78.7M | $120.2M | ||
| Q2 24 | $68.7M | $117.9M | ||
| Q1 24 | $77.8M | $122.9M |
总债务NATRPDFS
| Q4 25 | — | $67.0M | ||
| Q3 25 | — | $67.6M | ||
| Q2 25 | — | $68.1M | ||
| Q1 25 | — | $68.7M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.1M | — |
股东权益NATRPDFS
| Q4 25 | $161.6M | $271.0M | ||
| Q3 25 | $166.7M | $264.4M | ||
| Q2 25 | $163.7M | $257.5M | ||
| Q1 25 | $167.1M | $249.0M | ||
| Q4 24 | $161.0M | $246.0M | ||
| Q3 24 | $162.6M | $240.5M | ||
| Q2 24 | $156.4M | $232.2M | ||
| Q1 24 | $159.7M | $225.4M |
总资产NATRPDFS
| Q4 25 | $261.1M | $418.7M | ||
| Q3 25 | $264.8M | $406.4M | ||
| Q2 25 | $254.9M | $391.1M | ||
| Q1 25 | $252.7M | $390.0M | ||
| Q4 24 | $240.9M | $315.3M | ||
| Q3 24 | $245.3M | $307.4M | ||
| Q2 24 | $235.8M | $298.0M | ||
| Q1 24 | $247.3M | $286.8M |
负债/权益比NATRPDFS
| Q4 25 | — | 0.25× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | 0.26× | ||
| Q1 25 | — | 0.28× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.01× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $9.9M | $17.3M |
| 自由现金流经营现金流 - 资本支出 | $7.6M | $7.5M |
| 自由现金流率自由现金流/营收 | 6.1% | 12.1% |
| 资本支出强度资本支出/营收 | 1.9% | 15.7% |
| 现金转化率经营现金流/净利润 | 2.41× | — |
| 过去12个月自由现金流最近4个季度 | $28.8M | $-8.6M |
8季度趋势，按日历期对齐
经营现金流NATRPDFS
| Q4 25 | $9.9M | $17.3M | ||
| Q3 25 | $18.5M | $3.3M | ||
| Q2 25 | $4.3M | $-5.2M | ||
| Q1 25 | $2.6M | $8.6M | ||
| Q4 24 | $12.2M | $1.6M | ||
| Q3 24 | $9.6M | $9.3M | ||
| Q2 24 | $1.3M | $684.0K | ||
| Q1 24 | $2.2M | $-1.9M |
自由现金流NATRPDFS
| Q4 25 | $7.6M | $7.5M | ||
| Q3 25 | $16.8M | $-2.9M | ||
| Q2 25 | $3.0M | $-13.8M | ||
| Q1 25 | $1.5M | $535.0K | ||
| Q4 24 | $10.0M | $-4.0M | ||
| Q3 24 | $7.9M | $5.1M | ||
| Q2 24 | $-2.0M | $-4.6M | ||
| Q1 24 | $-1.5M | $-3.9M |
自由现金流率NATRPDFS
| Q4 25 | 6.1% | 12.1% | ||
| Q3 25 | 13.1% | -5.1% | ||
| Q2 25 | 2.6% | -26.6% | ||
| Q1 25 | 1.3% | 1.1% | ||
| Q4 24 | 8.5% | -8.0% | ||
| Q3 24 | 6.9% | 11.0% | ||
| Q2 24 | -1.9% | -11.1% | ||
| Q1 24 | -1.4% | -9.4% |
资本支出强度NATRPDFS
| Q4 25 | 1.9% | 15.7% | ||
| Q3 25 | 1.3% | 10.8% | ||
| Q2 25 | 1.2% | 16.5% | ||
| Q1 25 | 1.0% | 17.0% | ||
| Q4 24 | 1.9% | 11.3% | ||
| Q3 24 | 1.5% | 9.0% | ||
| Q2 24 | 3.0% | 12.8% | ||
| Q1 24 | 3.3% | 4.9% |
现金转化率NATRPDFS
| Q4 25 | 2.41× | — | ||
| Q3 25 | 3.46× | 2.54× | ||
| Q2 25 | 0.81× | -4.55× | ||
| Q1 25 | 0.55× | — | ||
| Q4 24 | — | 2.98× | ||
| Q3 24 | 2.21× | 4.20× | ||
| Q2 24 | 0.97× | 0.40× | ||
| Q1 24 | 0.94× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
PDFS
| Volumebased | $38.0M | 61% |
| Other | $24.4M | 39% |
